HCA Healthcare, Inc. $HCA Shares Sold by Brandywine Global Investment Management LLC

Brandywine Global Investment Management LLC lowered its position in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 2.1% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 191,451 shares of the company’s stock after selling 4,036 shares during the period. Brandywine Global Investment Management LLC’s holdings in HCA Healthcare were worth $89,381,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also made changes to their positions in HCA. Palisade Asset Management LLC purchased a new position in shares of HCA Healthcare during the third quarter worth $26,000. Holos Integrated Wealth LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at about $29,000. Ares Financial Consulting LLC acquired a new stake in HCA Healthcare during the fourth quarter worth about $31,000. JPL Wealth Management LLC acquired a new position in HCA Healthcare in the third quarter valued at approximately $33,000. Finally, Aventura Private Wealth LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $34,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $372.29 on Monday. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The firm has a market capitalization of $82.59 billion, a P/E ratio of 12.80, a PEG ratio of 1.18 and a beta of 1.12. The stock’s fifty day moving average is $439.51 and its two-hundred day moving average is $477.20.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. HCA Healthcare’s quarterly revenue was up 4.3% on a year-over-year basis. During the same quarter last year, the company earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.

Analyst Ratings Changes

HCA has been the topic of a number of recent analyst reports. Leerink Partners lowered their price target on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Oppenheimer dropped their target price on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Wells Fargo & Company lowered their price target on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a research report on Monday, April 27th. Jefferies Financial Group restated a “buy” rating and issued a $525.00 price objective on shares of HCA Healthcare in a research report on Friday, April 24th. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research note on Tuesday, April 28th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $506.14.

Get Our Latest Research Report on HCA Healthcare

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Recommended Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.